BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD.

Beijing Aosaikang Pharmaceutical Co., Ltd.

002755

CNE100001X92

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-05-30 EDT			5-day change	1st Jan Change
10.54 ^CNY	+2.53%		+1.05%	-2.59%

05-10	Aosaikang Pharma's Unit Gets Nod to Market Isavuconazole Sulfate for Injection	MT
04-28	Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Beijing Aosaikang Pharmaceutical Co., Ltd. Announces Directorate Appointments

February 21, 2022 at 02:37 pm

Beijing Aosaikang Pharmaceutical Co., Ltd., at its Extraordinary General Meeting of 2022 held on 18 February 2022 elected Wang Xiaowen, Zhou Suling and Ma Jingfei as non-independent directors.

Latest news about Beijing Aosaikang Pharmaceutical Co., Ltd.

Aosaikang Pharma's Unit Gets Nod to Market Isavuconazole Sulfate for Injection	05-10	MT
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-28	CI
Beijing Aosaikang Pharma's Unit Gets Nod to Market Delafloxacin for Injection	03-05	MT
Aosaikang Pharmaceutical Registers Breast Cancer Drug	01-23	MT
Aosaikang Pharmaceutical's Unit Gets Nod for Two Drugs	01-17	MT
Aosaikang Pharmaceutical's Unit Gets Nod to Trial ASKC202 Tablets	11-13	MT
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Aosaikang Pharmaceutical's Unit Gets Nod to Test Gastric Cancer Drug	23-10-17	MT
Beijing Aosaikang Pharmaceutical Co., Ltd.(XSEC:002755) added to S&P Global BMI Index	23-09-18	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Aosaikang Pharma's Unit Gets Nod to Amend Instructions for Heart Drug	23-08-07	MT
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
Aosaikang Pharma Unit Registers Acid Reflux Drug in China	23-04-17	MT
Aosaikang Pharma Registers Three Drugs	23-03-24	MT
Aosaikang Pharma US Unit Gets Regulatory Nod For Anti-Tumor Drug Trial	22-12-20	MT
Beijing Aosaikang Pharmaceutical Co., Ltd.(XSEC:002755) dropped from S&P Global BMI Index	22-12-19	CI
Aosaikang Pharma Wins Nod to Market Variant of Pfizer’s Breast Cancer Drug	22-11-21	MT
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-30	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-28	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2021, Payable on June 20, 2022	22-06-10	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021	22-05-23	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2021	22-05-05	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
Beijing Aosaikang Pharmaceutical Co., Ltd. cancelled the acquisition of Jiangsu Vedkang Medical Science and Technology Co., Ltd. from Changzhou Beiruishi Enterprise Management Co., Ltd., Changzhou Yisiyuan Enterprise Management Co., Ltd., Zhuang Xiaojin and Miao Donglin.	22-04-16	CI

Chart Beijing Aosaikang Pharmaceutical Co., Ltd.

Duration

Period

Chart Beijing Aosaikang Pharmaceutical Co., Ltd.

More charts

BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD., formerly Beijing New Oriental Star Petrochemical Engineering Co., Ltd., is a China-based company mainly engaged in pharmaceutical manufacturing business. The Company produces proton pump inhibitor injections through its subsidiary Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Sector

Pharmaceuticals

Calendar

2024-08-25 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD.	-2.59%	1.35B
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+31.70%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+14.40%	240B
NOVARTIS AG	+9.45%	210B
ROCHE HOLDING AG	-4.91%	206B
AMGEN INC.	+6.17%	164B

Other Pharmaceuticals